Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-26-021980
Filing Date
2026-05-08
Accepted
2026-05-08 16:15:33
Documents
17
Period of Report
2026-05-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 804716
2 GRAPHIC formdef14a_001.jpg GRAPHIC 6939
3 GRAPHIC proxy_001.jpg GRAPHIC 405310
4 GRAPHIC proxy_002.jpg GRAPHIC 409317
  Complete submission text file 0001493152-26-021980.txt   3314954

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE aztr-20251231.xsd EX-101.SCH 3419
6 XBRL DEFINITION FILE aztr-20251231_def.xml EX-101.DEF 3367
7 XBRL LABEL FILE aztr-20251231_lab.xml EX-101.LAB 53134
8 XBRL PRESENTATION FILE aztr-20251231_pre.xml EX-101.PRE 41980
20 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 3588
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41705 | Film No.: 26958554
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)